Search Results

There are 9979 results for: content related to: A modified MPTP treatment regime produces reproducible partial nigrostriatal lesions in common marmosets

  1. Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease

    Journal of Neuroscience Research

    Volume 93, Issue 12, December 2015, Pages: 1849–1864, Lacey Pflibsen, Katherine A. Stang, Michelle D. Sconce, Vanessa B. Wilson, Rebecca L. Hood, Charles K. Meshul and Suzanne H. Mitchell

    Version of Record online : 31 AUG 2015, DOI: 10.1002/jnr.23638

  2. You have free access to this content
    Pramipexole protects against MPTP toxicity in non-human primates

    Journal of Neurochemistry

    Volume 96, Issue 5, March 2006, Pages: 1315–1321, Mahmoud M. Iravani, Claire O. Haddon, J. Mark Cooper, Peter Jenner and Anthony H. Schapira

    Version of Record online : 8 FEB 2006, DOI: 10.1111/j.1471-4159.2005.03625.x

  3. You have free access to this content
    MPTP and MPP+ target specific aminergic cell populations in larval zebrafish

    Journal of Neurochemistry

    Volume 108, Issue 3, February 2009, Pages: 719–731, V Sallinen, V Torkko, M Sundvik, I Reenilä, D Khrustalyov, J Kaslin and P Panula

    Version of Record online : 27 NOV 2008, DOI: 10.1111/j.1471-4159.2008.05793.x

  4. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice

    European Journal of Neuroscience

    Volume 26, Issue 6, September 2007, Pages: 1500–1508, Zhen Hong, Gang Wang, Jing Gu, Jing Pan, Li Bai, Shi Zhang and Sheng-Di Chen

    Version of Record online : 20 AUG 2007, DOI: 10.1111/j.1460-9568.2007.05766.x

  5. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): Changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins

    Journal of Neuroscience Research

    Volume 83, Issue 2, 1 February 2006, Pages: 332–347, Giselle M. Petzinger, Beth Fisher, Elizabeth Hogg, Avery Abernathy, Pablo Arevalo, Kerry Nixon and Michael W. Jakowec

    Version of Record online : 29 DEC 2005, DOI: 10.1002/jnr.20730

  6. You have free access to this content
    Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism

    Neurogastroenterology & Motility

    Volume 21, Issue 2, February 2009, Pages: 215–222, T. Chaumette, T. Lebouvier, P. Aubert, B. Lardeux, C. Qin, Q. Li, D. Accary, E. Bézard, S. Bruley Des Varannes, P. Derkinderen and M. Neunlist

    Version of Record online : 10 DEC 2008, DOI: 10.1111/j.1365-2982.2008.01226.x

  7. Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning

    Journal of Neuroscience Research

    Volume 89, Issue 10, October 2011, Pages: 1698–1706, Natalie R.S. Goldberg, Tom Hampton, Scott McCue, Ajit Kale and Charles K. Meshul

    Version of Record online : 11 JUL 2011, DOI: 10.1002/jnr.22699

  8. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys

    Journal of Neuroscience Research

    Volume 87, Issue 2, 1 February 2009, Pages: 586–597, Pablo Garrido-Gil, Silvia Belzunegui, Waldy San Sebastián, Amaya Izal-Azcárate, Berta López, Irene Marcilla and Maria Rosario Luquin

    Version of Record online : 16 SEP 2008, DOI: 10.1002/jnr.21845

  9. You have free access to this content
    Inactivation of neuronal forebrain A2A receptors protects dopaminergic neurons in a mouse model of Parkinson’s disease

    Journal of Neurochemistry

    Volume 111, Issue 6, December 2009, Pages: 1478–1489, Anna R. Carta, Anil Kachroo, Nicoletta Schintu, Kui Xu, Michael A. Schwarzschild, Jadwiga Wardas and Micaela Morelli

    Version of Record online : 8 OCT 2009, DOI: 10.1111/j.1471-4159.2009.06425.x

  10. You have free access to this content
    Neuroprotective effect of l-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson’s disease: a direct comparison study

    Journal of Neurochemistry

    Volume 111, Issue 4, November 2009, Pages: 1042–1050, Jin Young Shin, Hyun-Jung Park, Young Hwan Ahn and Phil Hyu Lee

    Version of Record online : 16 SEP 2009, DOI: 10.1111/j.1471-4159.2009.06381.x

  11. Increased host neuronal survival and motor function in BMT Parkinsonian mice: Involvement of immunosuppression

    Journal of Comparative Neurology

    Volume 504, Issue 6, 20 October 2007, Pages: 690–701, Gilmor I. Keshet, Ravi J. Tolwani, Angelica Trejo, Peggy Kraft, Regis Doyonnas, Carol Clayberger, James M. Weimann and Helen M. Blau

    Version of Record online : 22 AUG 2007, DOI: 10.1002/cne.21483

  12. Exercise-induced behavioral recovery and neuroplasticity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse basal ganglia

    Journal of Neuroscience Research

    Volume 77, Issue 3, 1 August 2004, Pages: 378–390, Beth E. Fisher, Giselle M. Petzinger, Kerry Nixon, Elizabeth Hogg, Samuel Bremmer, Charles K. Meshul and Michael W. Jakowec

    Version of Record online : 20 MAY 2004, DOI: 10.1002/jnr.20162

  13. Synaptic microcircuitry of tyrosine hydroxylase-containing neurons and terminals in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys

    Journal of Comparative Neurology

    Volume 495, Issue 4, 1 April 2006, Pages: 453–469, Maney Mazloom and Yoland Smith

    Version of Record online : 16 FEB 2006, DOI: 10.1002/cne.20894

  14. Poly(ADP-ribose)polymerase inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice

    Journal of Neuroscience Research

    Volume 88, Issue 7, 15 May 2010, Pages: 1522–1536, Hironori Yokoyama, Hayato Kuroiwa, Tatsuya Tsukada, Hiroto Uchida, Hiroyuki Kato and Tsutomu Araki

    Version of Record online : 8 DEC 2009, DOI: 10.1002/jnr.22310

  15. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  16. You have free access to this content
    The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease

    Journal of Neurochemistry

    Volume 109, Issue 2, April 2009, Pages: 656–669, Belen Joglar, Jannette Rodriguez-Pallares, Ana Isabel Rodriguez-Perez, Pablo Rey, Maria Jose Guerra and Jose Luis Labandeira-Garcia

    Version of Record online : 20 FEB 2009, DOI: 10.1111/j.1471-4159.2009.05999.x

  17. You have free access to this content
    MPTP-induced changes in hippocampal synaptic plasticity and memory are prevented by memantine through the BDNF-TrkB pathway

    British Journal of Pharmacology

    Volume 172, Issue 9, May 2015, Pages: 2354–2368, Guoqi Zhu, Junyao Li, Ling He, Xuncui Wang and Xiaoqi Hong

    Version of Record online : 26 MAR 2015, DOI: 10.1111/bph.13061

  18. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  19. You have free access to this content
    Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease

    British Journal of Pharmacology

    Volume 164, Issue 4, October 2011, Pages: 1357–1391, Susan Duty and Peter Jenner

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1476-5381.2011.01426.x

  20. Forebrain dopamine depletion impairs motor behavior in lamprey

    European Journal of Neuroscience

    Volume 27, Issue 6, March 2008, Pages: 1452–1460, R. H. Thompson, A. Ménard, M. Pombal and S. Grillner

    Version of Record online : 10 MAR 2008, DOI: 10.1111/j.1460-9568.2008.06125.x